Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • Badminton India Launches on Fanly: A Game-Changing Platform for Badminton Stars-Fan Engagement Business
  • Infinite Health Solutions Collaborated With Top Laboratories and Hospitals to Provide Customized Healthcare Programs & Wellness Solutions Pan India Business
  • MK Jewels brings the rich jewel culture of every state in India to one venue Business
  • ISB Executive Education and Imarticus Learning Launch Programme for Chief Financial Officers Education
  • 25th CII Energy Efficiency Summit: Energy Efficiency Takes the Next Leap with AI, Electrification and Innovation Technology
  • Fort City Brewing and BYG BREWSKI Brewing Company Collaborate on Limited- Edition Cold IPA Business
  • Ajooni Biotech Ltd launches pilot project in Rajasthan for exploring potential in MORINGA farming Business
  • ‘The Tenth Riddle’ by Sapan Saxena garners rave reviews from critics across Press Release

Optimus Receives Tentative Approval from U.S. FDA for Brexpiprazole Tablets

Posted on October 9, 2021 By

Hyderabad (Telangana) [India], October 09: Optimus Pharma Private Limited today announced that it has received tentative approval from the United States Food and Drug Administration (FDA) for the generic equivalent of Rexulti® Tablets, 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, and 4 mg, of Otsuka Pharmaceutical Co., Ltd. Optimus Pharma’s approval for its Abbreviated New Drug Application (ANDA) BREXPIPRAZOLE Tablets, 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, and 4 mg, was received on October 8th, 2021. BREXPIPRAZOLE will be manufactured at Optimus Pharma’s Pashmylaram USFDA accredited facility in India.

BREXPIPRAZOLE Tablets (RLD: Rexulti® Tablets) had estimated annual sales of USD 1258 million in the U.S. (IQVIA MAT July 2021).

BREXPIPRAZOLE has a favourable antipsychotic profile in terms of improvement of cognitive performance and sleep patterns, as well as effects on affective states and potential to treat core symptoms in schizophrenia and major depressive disorder, including cognitive deficits with a low risk of adverse effects (extrapyramidal symptoms, metabolic complications, weight gain, akathisia potential) that are commonly encountered with other typical and second-generation antipsychotic drugs. From the studies done so far, it can be concluded that BREXPIPRAZOLE can be effective monotherapy for schizophrenia and as an adjunct to other antidepressant medications in major depressive disorder.

About Optimus Pharma

Optimus was established in the year 2004 as a custom synthesis laboratory by a team of techno-commercial experts. It is one of the fastest-growing Manufacturer in Active Pharmaceutical Ingredients (APIs) and Finished dosages. Over the last decade, we have been certified and audited by reputed Global Regulatory Agencies like USFDA, WHO, COFEPRIS, EMA, KFDA and AFM from PMDA Japan. Optimus Pharma is a vertically integrated pharmaceutical company engaged in the manufacturing of Solid Oral and semisolid formulations. We have successfully integrated our API and Formulation R&D teams, with the IP and Regulatory Affairs team in order to ensure a dynamic product portfolio. We help our customers serve global markets with technology based, innovative, cost effective & consumer friendly products of the highest quality.

Business Tags:Business

Post navigation

Previous Post: Abhijeet Anand Awarded 2021 International Young Professional Service Award By SPE During Annual Technical Conference And Exhibition In Dubai
Next Post: Outsmart Your Competitors and Opt for Online Dominance with World’s Best SEO Services – ThatWare

Related Posts

  • Captain Polyplast Limited Strengthens Solar EPC Order Book with Rs 47 Cr Order for 2,000 Solar Pumps from MSEDCL Business
  • Solidaridad & Centre for Responsible Business to launch regenagri Cotton Alliance, to Step up the Fight against Climate Change Business
  • Mayank Cattle Food Ltd. Board to Consider Bonus Share Issue Business
  • tlooto AI Highlights AcademicGPT at Startup Mahakumbh 2025, India’s Largest Startup and Innovation Event Business
  • Marengo CIMS Hospital commemorated International Women’s Day by holding a talk show for increased awareness of cancers in women Business
  • Mohit Yadav Takes A Step Towards Making India Digitally Safer By Training Young Indians In Cybersecurity Business

Recent Posts

  • IBMA Organises First-Ever Indian Lead Battery Conference 2026 in Goa
  • Why Creator-Gear is a B2B Business now: agencies, schools, and production houses?
  • Prateek Group Brings The New Era of Luxury Real Estate
  • Top Bathroom Tile Brands in India: Wall, Floor and Anti-Skid Options Compared
  • Parul University moves to 401-500 band in Times Higher Education (THE) Interdisciplinary Science Rankings 2027

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • The “Sanjhi Sanjh Connect Abhinandan” Program Strengthens Generational Bonds: Actor Anang Desai Participated Lifestyle
  • Sanjay Mishra Stars in Kunal Shamshere Malla’s ‘5th September’ – Trailer Unveiled for Inspiring Tribute to Mentors Entertainment
  • Indian Ad Veteran Raj Kamble Named Asia Chair for The ANDY Awards Regionals Business
  • Aurawick.com Launches Premium Handmade Luxury Candles, Sold Out in First 48 Hours Business
  • KAAM’s newest collaboration with LPG France in India promises to open up new avenues in the field of cosmetology Business
  • Mumbai’s Adsmagnify Enters Version 2.0 With AI Upgrades and Expanded Academy as It Targets Stronger Client Delivery in 2026 Business
  • DPS Bhagalpur and DPS Greater Ranchi’s celebration of Azadi Ka Amrit Mahotsav with the 75-meter-long national flag march got included in the World Book of Records Press Release
  • Galgotias University IEEE Computer Society Chapter Wins National Recognition at AICSSYC Education

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme